GDx variable cornea compensation with scanning laser polarimetry (SLP-VCC), Heidelberg retina tomography (HRT) confocal scanning laser ophthalmoscopy (CSLO) and stereoscopic optic nerve head (ONH) photographs may all be useful in assisting clinicians to diagnose glaucoma.
Trabeculectomy is in danger of becoming a technique performed only by sub-specialists with glaucoma fellowship training unless it becomes a mandatory feature in training programmes.
Phaco-trabeculotomy in addition to deep sclerectomy can offer significant reductions in intraocular pressure (IOP).
Systemic immunosuppression following corneal transplantation should be administered only under strict medical surveillance.
Manual small incision cataract surgery (MSCIS) with trypan blue staining of the anterior capsule is a safe and effective method of cataract extraction for patients with phacolytic glaucoma.
The ICARE anterior chamber phakic intraocular lens (IOL) with angle-supported haptics was designed five years ago by Corneal Laboratories (France) and attained the CE mark for demonstrating good efficacy and stability of refractive outcomes for the correction of high myopia. However, the safety profile of the lens was compromised by a number of anatomical limitations: a high vaulting that placed the optic too close to the endothelium and, because of the overall design of the lens, accurate sizing was difficult. In our clinic, in a series of 44 cases of conventional ICARE implantations, there were three reports of ovalisation and two of endothelial cell density decrease, which necessitated the removal of the lens.
Retinal specialists have a new therapy in their armoury: on January 24th 2007, the European Commission approved ranibizumab (Lucentis, Novartis) for the treatment of patients with wet age-related macular degeneration (AMD).
The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.
Carl Zeiss Meditec has received FDA clearance to market the laser keratome applications of it's Visumax femtosecond laser system.
Why is it that education & training are sometimes regarded as a chore and an unnecessary obligation?
Removal of soft cataracts with Aqualase (Alcon), theoretically carries less risk to the posterior capsule than phacoemulsification.
Lumenis has appointed Dov Ofer as its new designated Chief Executive Officer.
Outlined of a four-point scale that may help to simplify the assessment of a patient's risk of developing age-related macular degeneration (AMD).
The Centers for Medicare and Medicaid Services (CMS) has issued a ruling that will allow Medicare beneficiaries undergoing cataract surgery to choose an astigmatism-correcting intraocular lens (IOL).
Intraocular pressure (IOP) measurements with the Pascal dynamic contour tonometer (PDCT) are relatively immune to changes in corneal biomechanics and pachymetry, according to a study published in the January issue of the American Journal of Ophthalmology.
Could phakic IOLs some day emerge as the dominant refractive surgical approach, particularly considering the past problems with early innovations? This is a difficult question to answer but one that has been debated over recent years.
As with any IOL implantation technique, there are some potential complications that must be considered. In general, the number of complications is low, and most of them are either easy to avoid or easy to repair
SLT comparable with medical therapy for open angle glaucoma
The US Navy is proceeding with a programme allowing LASIK with IntraLase flap creation in naval aviators.
A rising number of phakic IOLs are steadily making their way into clinics, with each one offering its own unique property to set it apart from the competition. Documented studies will tout the benefits of each lens and, in many cases, will compare phakic lenses in head-to-head studies. Naturally, all studies are important and the benefits a particular kind of lens affords in a certain type of patient, is absolutely critical if a surgeon is to make an informed decision on his or her choice of lens. However, just as important as the choice of lens, is the surgical technique employed to implant the lens. A good technique will, amongst other things, reduce the incidence of potential complications that could ensue as a result of surgery and it will lead to a faster recovery time.
A new class of lipids, that makes up part of the tear film, has been identified, which could lead to insights into the role of fatty acid amide activity in the human biological system.
New technology is allowing clinicians, for the first time, to study the subtle structural changes that cause progression of this disease.
Retina specialists have a new therapy in their armoury: on January 24th 2007, the European Commission approved ranibizumab (Lucentis, Novartis) for the treatment of patients with wet age-related macular degeneration (AMD).
Bausch & Lomb has made an equity investment in AcuFocus.
The Ahmed glaucoma valve (AGV) and the Molteno single plate implant (MSPI) may provide good early and intermediate-term control of intraocular pressure (IOP) in patients with neovascular glaucoma (NVG), but do not achieve the same success when implanted for long periods.
A new fixed combination of dexamethasone and netilmicin offers an effective and safe way to control ocular inflammation after cataract surgery.
Advanced Medical Optics (AMO) has acquired two companies in a spending spree that has cost it approximately $828 million. The purchase of IntraLase Corp. represents a collaboration of two of the strongest performers in the refractive surgery market and the acquisition of WaveFront Sciences boosts AMO's quest for the custom all-laser LASIK.
An update of the ESCRS and ASCRS survey on the most common complications involving foldable IOLs.
The FDA has accepted iCoTherapeutics' Investigational New Drug (IND) application for iCo-007.
Alcon has received FDA approval for the AcrySof ReSTOR intraocular lens (IOL) for the correction of aphakia following cataract surgery in patients with or without presbyopia.
